Sanofi (SNYNF)
OTCMKTS · Delayed Price · Currency is USD
94.12
+2.59 (2.83%)
Jan 21, 2026, 4:00 PM EST
Sanofi Revenue
Sanofi had revenue of 13.17B EUR in the quarter ending September 30, 2025, with 1.49% growth. This brings the company's revenue in the last twelve months to 45.93B, up 4.55% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 6.41% growth.
Revenue (ttm)
45.93B EUR
Revenue Growth
+4.55%
P/S Ratio
2.10
Revenue / Employee
554.20K EUR
Employees
82,878
Market Cap
113.29B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 2.67B | 6.41% |
| Dec 31, 2023 | 41.62B | 1.06B | 2.61% |
| Dec 31, 2022 | 40.56B | 1.39B | 3.54% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | 37.63B | 1.95B | 5.48% |
| Dec 31, 2018 | 35.68B | -544.00M | -1.50% |
| Dec 31, 2017 | 36.22B | 1.53B | 4.40% |
| Dec 31, 2016 | 34.70B | -165.00M | -0.47% |
| Dec 31, 2015 | 34.86B | 2.86B | 8.94% |
| Dec 31, 2014 | 32.00B | 708.00M | 2.26% |
| Dec 31, 2013 | 31.29B | -4.67B | -12.98% |
| Dec 31, 2012 | 35.96B | 899.00M | 2.56% |
| Dec 31, 2011 | 35.06B | 1.02B | 3.00% |
| Dec 31, 2010 | 34.04B | 2.80B | 8.98% |
| Dec 31, 2009 | 31.23B | 2.42B | 8.38% |
| Dec 31, 2008 | 28.82B | -390.00M | -1.34% |
| Dec 31, 2007 | 29.21B | -282.00M | -0.96% |
| Dec 31, 2006 | 29.49B | 976.00M | 3.42% |
| Dec 31, 2005 | 28.51B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
Sanofi News
- 12 hours ago - Bear Mountain Capital, Inc. Sells 222 Shares of Sanofi SA (SNY) - GuruFocus
- 12 hours ago - Sanofi CEO Paul Hudson: AI will improve efficiency and change the cost and speed of drug development - CNBC
- 1 day ago - Runnymede Capital Advisors, Inc. Buys 15,632 Shares of Sanofi SA (SNY) - GuruFocus
- 1 day ago - Independence Bank of Kentucky Buys 76 Shares of Sanofi SA (SNY) - GuruFocus
- 3 days ago - Oakmark Global Select Fund Adds Sanofi (SNY) in Q4 2025 - GuruFocus
- 7 days ago - Sanofi (SNY) Plans Enhanced Offer for Ocular Therapeutix - GuruFocus
- 7 days ago - Why Sanofi May Need To Top $2.4 Billion For Ocular Therapeutix - Seeking Alpha
- 7 days ago - Ocular Therapeutix Shares Surge Following Reports Of Stronger Sanofi Bid - Benzinga